Thrombectomy With the pRESET vs Solitaire Stent Retrievers as First-Line Large Vessel Occlusion Stroke Treatment

Overview of attention for article published in JAMA Neurology, February 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

news: 9 news outlets
twitter: 26 X users

facebook: 2 Facebook pages

Readers on

mendeley: 45 Mendeley

So far, Altmetric has seen 10 news stories from 9 outlets.

WallabyPhenox Boldly Sets New Benchmark in Evidence-Based Medicine With the PROST Trial

AP News, 05 Feb 2024

PROST Stroke Trial Results Published in JAMA Neurology IRVINE, CA / ACCESSWIRE / February 5, 2024 / WallabyPhenox, a global…

News story from Finanz Nachrichten on Monday 05 February 2024

Finanz Nachrichten, 05 Feb 2024

WallabyPhenox Boldly Sets New Benchmark in Evidence-Based Medicine With the PROST Trial

Arab Press Releases.com, 05 Feb 2024

PROST Stroke Trial Results Published in JAMA Neurology IRVINE, CA / ACCESSWIRE / February 5, 2024 / WallabyPhenox, a global…

WallabyPhenox Boldly Sets New Benchmark in Evidence-Based Medicine With the PROST Trial

Morning Star, 05 Feb 2024

PROST Stroke Trial Results Published in JAMA Neurology IRVINE, CA / ACCESSWIRE / February 5, 2024 / WallabyPhenox, a global…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 6 additional news stories.